J&J to cut 8190 jobs in these difficult times.
Johnson & Johnson, the consumer goods and healthcare giant, said that it would cut up to 7% of its 117000 employees worldwide, meaning that as many as 8190 people could lose their jobs.
Johnson & Johnson is the latest healthcare company to have decided to slash costs to negotiate the difficulties of funding research into new medicines. As patents on some of its biggest-selling drugs are close to expiring, it needs to find fresh treatments to fill the gap in revenues. However, bringing a new drug to market costs more than $1 billion (£609 million), with many failing in early stage clinical trials.
By 2011, Johnson & Johnson hopes to save $1.4 billion to $1.7 billion a year through the cuts, with an $800 mill-ion to $900 million cost reduction expected next year. It had already cut about 3 per cent of its workforce in July 2007.
William Weldon, chief executive of Johnson & Johnson, said:
This is what we need to do to ‘rightsize’ the company to make sure we have the resources to invest.
Job losses = 6190
Source: Business Times Online
Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically each day to your feed reader. Alternatively you can follow us on Twitter.
